The Daily Fuckup

The Justice Department said on May 6, 2026, that it concluded the David Geffen School of Medicine at UCLA discriminated on the basis of race in its admissions process. The finding came from the Civil Rights Division after what the department described as a year-long investigation. It is not a court ruling, and it does not itself rewrite the law. But it is an official federal determination that puts one of the country’s best-known public medical schools at the center of a broader push to attack race-conscious decision-making from Washington.

The department said its review found evidence that UCLA’s leadership intentionally selected applicants based on race and that admitted Black and Hispanic applicants had, on average, lower academic qualifications than white and Asian applicants. In the government’s telling, that amounts to a Title VI violation. UCLA has not been shown in the official record here to have changed policy in response, but the finding gives the administration a public enforcement target and a legal narrative it can use well beyond one campus.

The timing matters. On June 9, the Justice Department said the Office of Legal Counsel had concluded EEOC disparate-impact guidance is unconstitutional, part of the administration’s larger effort to narrow federal civil-rights enforcement inside the executive branch. Together, the two moves point in the same direction: the government is not just arguing against race-conscious policy in the abstract, it is using enforcement and legal opinions to say that practices tied to racial outcomes are presumptively suspect. That is a major shift in posture, and institutions watching from the sidelines are likely to notice.

For universities, the message is blunt. Admissions systems that consider race, even indirectly, now face a federal government more willing to treat them as violations than as legitimate efforts to build diverse classes. Supporters of the administration will call that overdue enforcement of equal-treatment rules. Critics will see it as an attempt to strip away tools used to address long-standing barriers that are often visible only in the aggregate. Either way, the effect is not theoretical. When the Justice Department labels a medical school’s admissions process discriminatory, the reputational hit comes immediately, long before any judge weighs in.

That also helps explain why this fight is bigger than UCLA. Public universities, medical schools, and state systems have spent years trying to navigate the gap between diversity goals and legal exposure. A federal finding like this can trigger follow-on investigations, pressure to change admissions criteria, and litigation if the school resists. It can also chill behavior elsewhere, as administrators tighten review or scrub race-related language from their processes to avoid becoming the next target.

What happens next will depend on whether UCLA contests the finding and whether the Justice Department follows with additional enforcement. But the direction of travel is clear enough already. The administration is trying to recast civil-rights enforcement so that race-conscious policies are treated less like a remedy for unequal access and more like the problem itself. The UCLA finding, paired with the June 9 EEOC opinion, shows that the campaign is not just rhetorical. It is being written into federal action.